Trial Profile
A Multi-center Clinical Study to Evaluate the Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Subjects With Suspected Metastatic Renal Cell Carcinoma.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Jun 2023
Price :
$35
*
At a glance
- Drugs Technetium Tc99m etarfolatide (Primary) ; Folic acid
- Indications Renal cell carcinoma
- Focus Diagnostic use; Proof of concept
- Sponsors Endocyte
- 27 Apr 2015 New trial record